CFS Investment Advisory Services LLC reduced its position in shares of SPDR Dow Jones Global Real Estate ETF (NYSEARCA:RWO – Free Report) by 11.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,254 shares of the company’s stock after selling […]
Tower Research Capital LLC TRC boosted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 208.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 201,060 shares of the biopharmaceutical company’s stock after acquiring an additional 135,782 shares during the quarter. Tower […]
Tower Research Capital LLC TRC boosted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 208.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 201,060 shares of the biopharmaceutical company’s stock after acquiring an additional 135,782 shares during the quarter. Tower […]
Douglas Emmett, Inc. (NYSE:DEI – Get Free Report) saw a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 19,610,000 shares, a decrease of 7.9% from the April 30th total of 21,290,000 shares. Based on an average daily volume of 1,550,000 shares, the short-interest ratio […]
Bank of Nova Scotia grew its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 43.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 427,751 shares of the biopharmaceutical company’s stock after buying an additional 130,552 shares during the […]